Dr Reddy's, FDC recall products in US for manufacturing issues
Dr Reddy's Laboratories and FDC Ltd are recalling generic medications in the US market due to manufacturing issues, according to the US health regulator. As per the latest Enforcement Report by Food and Drug Administration (USFDA), the US-based subsidiary of Dr Reddy's Laboratories is recalling multiple strengths of Morphine Sulfate extended-release tablets in the US.
The medication is used to relieve severe and persistent pain.
As per the USFDA, Princeton-based Dr Reddy's Laboratories Inc is recalling 2,040 bottles of 15 mg Morphine Sulfate extended-release tablets due to «Failed Impurities/Degradation Specification».
The drugmaker is also recalling another 532 100-count bottles of the medication in 30 mg strength for the same reason, USFDA stated.
Dr Reddy's initiated the Class II nationwide recall on October 22 this year.
Artificial Intelligence(AI)
ChatGPT Mastery from Zero to Hero: The Complete AI Course
By — Metla Sudha Sekhar, IT Specialist and Developer
Web Development
Master RESTful APIs with Python and Django REST Framework: Web API Development
By — Metla Sudha Sekhar, IT Specialist and Developer
Artificial Intelligence(AI)
Basics of Generative AI: Unveiling Tomorrow's Innovations
By — Metla Sudha Sekhar, IT Specialist and Developer
Finance
Financial Literacy for Non-Finance Executives
By — CA Raja, Chartered Accountant | Financial Management Educator | Former AVP — Credit, SBI
Artificial Intelligence(AI)
Master in Python Language Quickly Using the ChatGPT Open AI
By — Metla Sudha Sekhar, IT Specialist and
